FIP1L1-PDGFRA in eosinophilic disorders: Prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature-Reference-Cited by-同舟云学术

FIP1L1-PDGFRA in eosinophilic disorders: Prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature

Published:2006-08 Issue:8 Volume:30 Page:965-970
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Pardanani A.,Ketterling R.P.,Li C.-Y.,Patnaik M.M.,Wolanskyj A.P.,Elliott M.A.,Camoriano J.K.,Butterfield J.H.,Dewald G.W.,Tefferi A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference19 articles.

1. Chronic eosinophilic leukemia and the hypereosinophilic syndrome;Bain,2001

2. Molecular classification and pathogenesis of eosinophilic disorders: 2005 update;Gotlib;Acta Haematol,2005

3. Imatinib targets other than bcr/abl and their clinical relevance in myeloid disorders;Pardanani;Blood,2004

4. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome;Cools;N Engl J Med,2003

5. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness;Klion;Blood,2003

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicals;Current Hematologic Malignancy Reports;2024-07-22

2. Dyspneic and pink;Journal of Hospital Medicine;2024-04-02

3. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management;American Journal of Hematology;2024-03-29

4. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management;American Journal of Hematology;2024-03-07

5. Eosinophilia and the Hypereosinophilic Syndrome: Clinical, Molecular and Translational Aspects;Comprehensive Hematology and Stem Cell Research;2024